BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18671027)

  • 1. Pathogenicity and immunological relationship of quail and mynah poxviruses to fowl and pigeon poxviruses.
    Reed WM; Fatunmbi OO
    Avian Pathol; 1993 Jun; 22(2):395-400. PubMed ID: 18671027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity and immunogenicity of mynah pox virus in chickens and bobwhite quail.
    Reed WM; Schrader DL
    Poult Sci; 1989 May; 68(5):631-8. PubMed ID: 2547209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a commercial quail pox vaccine (Bio-Pox Q) for the control of "variant" fowl poxvirus infections.
    Fatunmbi OO; Reed WM
    Avian Dis; 1996; 40(4):792-7. PubMed ID: 8980808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian pox: infection and immunity with quail, psittacine, fowl, and pigeon pox viruses.
    Winterfield RW; Reed W
    Poult Sci; 1985 Jan; 64(1):65-70. PubMed ID: 2579373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and immunity with a virus isolate from turkeys.
    Winterfield RW; Reed WM; Thacker HL
    Poult Sci; 1985 Nov; 64(11):2076-80. PubMed ID: 2999743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
    Swayne DE; Beck JR; Kinney N
    Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psittacine pox virus: virus isolation and identification, transmission, and cross-challenge studies in parrots and chickens.
    Boosinger TR; Winterfield RW; Feldman DS; Dhillon AS
    Avian Dis; 1982; 26(2):437-44. PubMed ID: 6285884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual pox lesions found in Chinese jungle mynahs (Acridotheres cristatellus).
    Hsieh YC; Chen SH; Wang CW; Lee YF; Chung WC; Tsai MC; Chang TC; Lien YY; Tsai SS
    Avian Pathol; 2005 Oct; 34(5):415-7. PubMed ID: 16236575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a commercial modified live virus fowl pox vaccine for the control of "variant" fowl poxvirus infections.
    Fatunmbi OO; Reed WM
    Avian Dis; 1996; 40(3):582-7. PubMed ID: 8883788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticuloendotheliosis virus (REV) long terminal repeats incorporated in the genomes of commercial fowl poxvirus vaccines and pigeon poxviruses without indication of the presence of infectious REV.
    Moore KM; Davis JR; Sato T; Yasuda A
    Avian Dis; 2000; 44(4):827-41. PubMed ID: 11195637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological changes of tracheal mucosa in chickens infected with fowl pox virus.
    Tanizaki E; Kotani T; Odagiri Y
    Avian Dis; 1987; 31(1):169-75. PubMed ID: 3034227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity and cross-protection of pigeon paramyxovirus-1 and Newcastle disease virus in young chickens.
    Gelb J; Fries PA; Peterson FS
    Avian Dis; 1987; 31(3):601-6. PubMed ID: 2960315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibodies against fowl poxvirus.
    Singh P; Tripathy DN
    Avian Dis; 2000; 44(2):365-71. PubMed ID: 10879917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of highly pathogenic avian influenza viruses of H5N1 subtype isolated in Thailand for different poultry species.
    Saito T; Watanabe C; Takemae N; Chaisingh A; Uchida Y; Buranathai C; Suzuki H; Okamatsu M; Imada T; Parchariyanon S; Traiwanatam N; Yamaguchi S
    Vet Microbiol; 2009 Jan; 133(1-2):65-74. PubMed ID: 18675524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
    Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
    Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge.
    Yu L; Liu W; Schnitzlein WM; Tripathy DN; Kwang J
    Avian Dis; 2001; 45(2):340-8. PubMed ID: 11417813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticuloendotheliosis virus integration in the fowl poxvirus genome: not a recent event.
    Kim TJ; Tripathy DN
    Avian Dis; 2001; 45(3):663-9. PubMed ID: 11569741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization against pox. Studies on fowl pox as a model.
    Mayr A; Danner K
    Dev Biol Stand; 1976; 33():249-59. PubMed ID: 182584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.